Menu Back toBreak Out Sessions 2A: Complex Innovative Design Trials

Clinical Trials and Data Science Conference

Break Out Sessions 2A: Complex Innovative Design Trials

Session Chair(s)

Daniel  Millar, MBA

Daniel Millar, MBA

  • Senior Director, Strategic Business Transformation
  • Janssen Research & Development, United States
Complex Innovative Design Trials


Cecile  Spiertz, MSc

Deliverables from IMI EU-PEARL and How these will be Sustained Post-Project

Cecile Spiertz, MSc

  • Senior Director, External Innovation Clinical Trial Platforms
  • Janssen, Netherlands
Jonathan  Mackinnon, PhD

Protocol Development for Master Protocol Studies – Balancing Structure with Function

Jonathan Mackinnon, PhD

  • Associate Director, Medical Writing Services
  • Parexel, Spain
Christine  Fletcher, MSc

Acceptance of Design and Data of Complex Innovative Design Trials by Key Decision-Makers

Christine Fletcher, MSc

  • VP/Head, Speciality and Primary Care Statistics
  • GlaxoSmithKline, United Kingdom
Olga  Kholmanskikh Van Criekingen

Panel discussion with Q&A

Olga Kholmanskikh Van Criekingen

  • Clinical Assessor, CTCG Working Group member
  • Federal Agency for Medicines and Health Products, Belgium

Contact us

Registration Questions?

Send Email
+41 61 225 51 51